404 related articles for article (PubMed ID: 3332858)
1. Chromosome abnormalities in CML.
Hagemeijer A
Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
[TBL] [Abstract][Full Text] [Related]
2. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
Johansson B; Fioretos T; Mitelman F
Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388
[TBL] [Abstract][Full Text] [Related]
4. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
5. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
[TBL] [Abstract][Full Text] [Related]
6. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
8. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
[TBL] [Abstract][Full Text] [Related]
9. The molecular pathology of chronic myelogenous leukaemia.
Kurzrock R; Talpaz M
Br J Haematol; 1991 Oct; 79 Suppl 1():34-7. PubMed ID: 1931706
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations.
Abe S; Minamihisamatsu M; Ishihara T; Sasaki M
Cancer Genet Cytogenet; 1989 Mar; 38(1):61-74. PubMed ID: 2713815
[TBL] [Abstract][Full Text] [Related]
11. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
12. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
13. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
[TBL] [Abstract][Full Text] [Related]
14. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
15. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
Reid AG; Tarpey PS; Nacheva EP
Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
Liu K; Hu J; Wang X; Li L
J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758
[TBL] [Abstract][Full Text] [Related]
17. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
[TBL] [Abstract][Full Text] [Related]
19. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]